ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 23, 2017

Study Completion Date

March 21, 2018

Conditions
Persistent Atrial FibrillationLongstanding Persistent Atrial Fibrillation
Interventions
DEVICE

Synergy Ablation System

"Patient will undergo an elective open cardiac surgical procedure to be performed on cardiopulmonary bypass for one or more of the following:~* Coronary Artery Bypass Grafting (CABG)~* Mitral valve repair or replacement~* Aortic valve repair or replacement~* Tricuspid valve repair or replacement The aim of the treatment is a complete bi-atrial Maze IV procedure which includes pulmonary vein isolation coupled with lesions made on both the left and right atria."

Trial Locations (49)

15212

Allegheny General Hospital, Pittsburgh

17101

Pinnacle Health Hospitals, Harrisburg

19104

Hospital of the University of Pennsylvania (HUP), Philadelphia

23298

Virginia Commonwealth University, Richmond

23507

Sentara Norfolk General Hospital, Norfolk

27401

Triad Cardiac and Thoracic Surgeons/Cone Health, Greensboro

28203

Carolinas Medical Center, Charlotte

28803

Mission Hospital/Asheville Heart, Asheville

30308

Emory University Hospital, Atlanta

32611

University of Florida Cardiothoracic Surgery, Gainesville

33612

James A. Haley Veteran's Hospital/Cardiothoracic Surgery, Tampa

33613

Pepin Heart Hospital, Tampa

33701

Bayfront Medical Center, St. Petersburg

33709

Northside Hospital, St. Petersburg

33901

Lee Memorial Hospital, Fort Myers

35294

University of Alabama-Birmingham, Birmingham

38120

Baptist Memorial Hospital, Memphis

43606

Toledo Hospital, Toledo

44106

University Hospitals of Cleveland, Cleveland

45242

Good Samaritan Hospital, Cincinnati

46237

St. Francis Heart Hospital, Indianapolis

46290

Inidiana Heart Center, Indianapolis

48073

William Beaumont Hospital, Royal Oak

48109

University of Michigan, Ann Arbor

48910

Sparrow Clinical Research Institute, Lansing

49506

Spectrum Health, Grand Rapids

49684

Munson Medical Center, Traverse City

54401

Aspirus Wausau Hospital, Wausau

55102

United Heart & Vascular/Abbott Northwestern Hospital, Minneapolis

58201

Altru Health System, Grand Forks

60208

Northwestern Memorial Hospital, Evanston

62794

SIU- Memorial Medical Center, Springfield

63110

Washington University, St Louis

63131

Missouri Baptist Medical Center, St Louis

68526

Nebraska Heart, Lincoln

73135

Oklahoma Heart Hospital, Oklahoma City

75390

UT Southwestern University Hospital, Dallas

84124

St. Mark's Hospital, Salt Lake City

85258

Scottsdale Healthcare Clinical Research Institute, Scottsdale

90033

USC University Hospital, Los Angeles

90048

Cedars-Sinai Medical Center, West Hollywood

90095

Ronald Reagan UCLA Medical Center, Los Angeles

92123

Sharp Memorial Hospital, San Diego

97239

Oregon Health and Science University, Portland

98122

Swedish Medical Center, Seattle

06102

Hartford Hospital, Hartford

04102

Maine Medical Center, Portland

02132

Veteran Affairs Boston Healthcare System, West Roxbury

07503

St. Joseph's Regional Medical Center, Paterson

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AtriCure, Inc.

INDUSTRY

NCT01694563 - ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation | Biotech Hunter | Biotech Hunter